<DOC>
	<DOCNO>NCT00918008</DOCNO>
	<brief_summary>The purpose study evaluate new genetic-based test identify patient diagnose muscle-invasive bladder cancer surgery , might specific gene , increase chance recurrence cancer surgery . Some patient diagnose bladder cancer bladder remove , recurrence cancer sometime surgery . This recurrence usually cause tumor cell originate bladder tumor travel part body , call metastatic cancer . Some patient likely others metastatic disease . This test may help identify patient might develop metastasis specific gene .</brief_summary>
	<brief_title>A 12-Gene Blood-Based Signature Detecting Metastatic Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Patients pelvic lymph node dissection perform ; Any male and/or female , â‰¥18 year age ; Pathological diagnosis urothelial carcinoma bladder ; Localized muscleinvasive disease define clinical stage T24aN0M0 tumor ; Did receive neoadjuvant therapy ; No radiographic evidence metastatic disease CT scan abdomen pelvis , chest xray , bone scan ; Informed consent study participation Prior systemic chemotherapy ; Prior radiation therapy ; A history another ongoing malignancy within past 5 year basal cell carcinoma skin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>URINARY BLADDER</keyword>
	<keyword>Bladder</keyword>
	<keyword>Blood sample</keyword>
	<keyword>Lymph Nodes</keyword>
</DOC>